Jan 31, 2007 “I focus on instrumentation for detection and sensing systems -- not imaging or clinical therapeutic uses. The overall market opportunity, for all technologies, in detection systems and sensors across agriculture, homeland security, biomedical diagnosis and the military, is estimated to be about $16 billion,” said Krohn. “If you drill down and just look at biophotonics and photonics detection systems, the market potential is still over $2 billion by the year 2011.”
Among the biotech areas under study at Breault, he said, are an optical means of glucose measurement; illumination and imaging for surgical instruments; and light-source modeling for biophotonics, or the study of the interaction between biological materials and light.
A doctor who works with a local optics firm said medical optics technologies are quickly moving beyond diagnostics to advanced therapeutic tools. "They're talking about going deep inside the body with these biooptics machines," said Dr. Larry Marsteller, a UA-educated physician and director of medical products for CDEX Inc. in Tucson.
CDEX, based in Rockville, Md., is developing X-ray and ultraviolet explosives-detection systems for military and homeland-defense applications and an optical pill-identification system. The company's principal scientist, former UA Steward Observatory researcher Wade Poteet, said he hopes to collaborate with UA scientists on new biological detection technologies.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.